UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	August 16, 2013 12:00 P.M.

Form:	S-3
CIK: 0001114220 Company Name: KERYX BIOPHARMACEUTICALS INC File Number: 333-190353